Skip to main content
OpenTrials
Completed

NCT Number: NCT03541577

Sensor-equipped Ultrathin Pressure Microcatheter Versus Pressure Wire for FFR Measurement

TruePhysioTM Sensor-equipped Ultrathin Pressure Microcatheter (referred to as TruePhysioTM Microcatheter below) is a novel device for evaluating the functional significance of coronary stenosis. This study will compare the differences, if any, between the coronary fractional flow reserve (FFR) measured by the TruePhysioTM Microcatheter and the Pressure Wire.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–75 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Guangdong General Hospital, Guangzhou, China

Loading trial locations.

About this study

Many studies have reported that FFR-guided coronary revascularization leads to improved long-term clinical outcomes and reduced costs compared with angiography-guided coronary revascularization alone. Current guidelines emphasize the measurement of FFR as the standard of reference when determining the functional significance of coronary artery stenosis in stable patients when evidence of ischemia is not available (class IA indication). But FFR is still underutilized in clinical practice. One of the reasons may be the difficulty in manipulating the Pressure Wire.

TruePhysioTM Microcatheter is a novel device for evaluating the functional significance of coronary stenosis, which may simplify FFR measurements by allowing the use of standard guidewires best suited to negotiating the patients' anatomy. This study is a prospective, open label, multi-center study with the purpose of comparing the differences, if any, between FFR measured by the TruePhysioTM Microcatheter and Pressure Wire. The secondary purpose is to analyze the correlation between FFR measured by the TruePhysioTM Microcatheter and Pressure Wire. A total of 239 patients will be recruited at 4 centers in China.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

General Inclusion Criteria:

  • Age: 18-75 years old
  • Subjects with coronary artery disease
  • Able to understand and provide signed consent

Angiographic Inclusion Criteria:

  • Subject has an intermediate stenosis in a native coronary vessel
  • The target stenosis has a reference diameter ≥2.50 mm by visual assessment.

Exclusion criteria

General Exclusion Criteria:

  • Acute ST-elevation or non-ST-elevation myocardial infarction
  • Severe heart failure (NYHA≥IV)
  • Left ventricular ejection fraction <30%
  • Allergy to adenosine triphosphate (ATP)
  • Contraindications for percutaneous coronary intervention (PCI)

Angiographic Exclusion Criteria:

  • Target vessel has angiographically visible or suspected thrombus
  • Angiographic evidence of a dissection
  • Excessive tortuosity or calcification stenosis, left main stenosis, serial stenosis

Treatment and study plan

TruePhysioTM Microcatheter

Device

Provide hemodynamic information for the diagnosis and treatment of coronary and peripheral artery disease. The system is intended for use in catheterization and related cardiovascular specialty laboratories to compute and display fractional flow reserve (FFR).

Other names: FFR Microcatheter

Pressure Wire

Device

Provide hemodynamic information for the diagnosis and treatment of coronary and peripheral artery disease. The system is intended for use in catheterization and related cardiovascular specialty laboratories to compute and display fractional flow reserve (FFR).

Other names: PressureWire

Primary outcomes

  1. FFR Measurements

    Time frame: Duration of FFR measurement

    Comparisons between the FFR measured by the TruePhysioTM Microcatheter and the Pressure Wire (PW), including bias, as assessed by Bland-Altman analysis.

Secondary outcomes

  1. Pearson analysis

    Time frame: Duration of FFR measurement

    Pearson analysis of paired FFR measurements by TruePhysioTM Microcatheter and PW.

  2. Slope of Passing-Bablok fit

    Time frame: Duration of FFR measurement

    Slope of Passing-Bablok fit between paired FFR measurements by TruePhysioTM Microcatheter and PW.

  3. Intercept of Passing-Bablok fit

    Time frame: Duration of FFR measurement

    Intercept of Passing-Bablok fit between paired FFR measurements by TruePhysioTM Microcatheter and PW.

  4. Diagnostic FFR concurrence of functionally significant stenosis

    Time frame: Duration of FFR measurement

    Concurrence of TruePhysioTM Microcatheter FFR diagnostic accuracy of functionally significant stenosis, using PW FFR ≤0.80 as the reference.

  5. Sensitivity, Specificity of TruePhysioTM Microcatheter in determining functionally significant stenosis

    Time frame: Duration of FFR measurement

    Sensitivity, Specificity of TruePhysioTM Microcatheter in determining functionally significant stenosis at the vessel level with PW FFR as the reference standard (PW FFR ≤0.80 as positive case).

  6. Device success rate

    Time frame: Duration of FFR measurement

    Device success rate, defined as a valid FFR reading for each system, and comparison between the two systems.

  7. Mean drift

    Time frame: Duration of FFR measurement

    Mean drift, defined as the absolute difference between Pd/Pa at the equalization position after pullback and 1.00, for each system, and comparison between the two systems.

  8. Rate of clinically significant drift

    Time frame: Duration of FFR measurement

    Rate of clinically significant drift (drift >0.03), for each system, and comparison between the two systems.

  9. Rate of device-related adverse effects

    Time frame: Duration of FFR Procedure

    Rate of device-related adverse effects, for each system individually, and comparison between the two systems.

  10. PW FFR measurements with TruePhysioTM Microcatheter across and not across lesion

    Time frame: Duration of FFR Procedure

    Comparisons between PW FFR measurements with TruePhysioTM Microcatheter across lesion and with TruePhysioTM Microcatheter not across lesion, including bias, as assessed by Bland-Altman analysis.

Sponsors and collaborators

Lead sponsor

Insight Lifetech Co., Ltd.

Industry

Collaborators

  • Guangdong Provincial People's Hospital
  • Second Affiliated Hospital, School of Medicine, Zhejiang University
  • Shanghai Zhongshan Hospital
  • Shenzhen People's Hospital

Registry information

Official study title

Sensor-equipped Ultrathin Pressure Microcatheter Versus Pressure Wire for FFR Measurement: A Multi-center Prospective Control Study

Acronym: SUPREME

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
May 30, 2018
Registry last updated
May 27, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.